Natural Capsules Limited
142.82
INR
-7.51
(-5.00%)
ISIN
INE936B01015
Return %
Stock
S&P 500
1Y
-36.61
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Sunil Laxminarayan Mundra
- Full Time Employees
- 620
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Trident Towers Bangalore KA India 560011
- IPO Date
- Aug 3, 1994
- Website
- naturalcapsules.com
- Similar Companies
- Business
- Natural Capsules Limited engages in the manufacture and sale of empty hard gelatin and hydroxypropyl methylcellulose (HPMC) capsules, serving the pharmaceutical and dietary supplement industries. Its core products include hard gelatin capsule shells in sizes 00, 0EL, 0, 1, 2, 3, and 4 made from pharmaceutical grade gelatin derived from bovine sources; HPMC vegetarian capsules in similar sizes; specialized gelatin capsules such as titanium dioxide (TiO2) free capsules for compliance with European regulations; printed and unprinted capsule shells; fast release and fortified gelatin capsules; and customized capsule printing services. The company also provides encapsulation services for herbal, nutraceutical, and non-betalactam formulations and manufactures pharmaceutical dosage forms in capsule format. It operates modern manufacturing facilities in Bangalore and Pondicherry, India, with certifications including WHO-GMP, EU GMP, USDMF, HALAL, KOSHER, ISO 9001, and regulatory approvals from US FDA, EDQM, TGA, MCC, and MHRA, supplying to nearly 350 pharmaceutical companies in India and exporting to 34 countries. Founded in 1993 and headquartered in Bengaluru, India, Natural Capsules Ltd has expanded its product portfolio into active pharmaceutical ingredients (APIs) and steroidal APIs through a subsidiary, Natural Biogenex Private Limited. In the last 1-2 years, the company has focused on strengthening its market position by upgrading manufacturing facilities to meet evolving international quality standards and compliance requirements. It continues to innovate with new product lines such as TiO2 free capsules to meet stringent EU regulations and enhance its global competitiveness. The company maintains a strategic commitment to leadership in cellulose capsule supply and pharmaceutical dosage form formulation, reflecting a clear business expansion into integrated capsule manufacturing and formulation services. Natural Capsules Limited operates within the pharmaceuticals and biotechnology sector, targeting pharmaceutical companies and dietary supplement manufacturers globally. Its extensive product range and advanced services cater to both domestic and international markets. The company’s strategic facilities in Bangalore and Pondicherry enable efficient production and distribution. Natural Capsules is recognized for its high-quality capsules known for machinability, precision, and compliance with cGMP and cGLP standards. Recent operational updates emphasize financial growth with increased net sales year-on-year, alongside ongoing board-level governance and management enhancements. This comprehensive product and service portfolio, combined with recent quality certifications and operational improvements, positions Natural Capsules Limited as a key supplier of hard gelatin and HPMC capsules and pharmaceutical formulations with a growing footprint in global pharmaceutical markets.